Phosphorylation of tau protein at sites Ser396-404is one of the earliest events in Alzheimer's disease and Down syndrome

Interaction of Endogenous Tau Protein with Synaptic Proteins Is Regulated byN-Methyl-d-aspartate Receptor-dependent Tau Phosphorylation

(2012) Siddhartha Mondragón-Rodríguez et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level

(2012) Georg Nübling et al.   Molecular Neurodegeneration

Positron Emission Tomography of Brain β-Amyloid and Tau Levels in Adults With Down Syndrome

(2011) Linda D. Nelson et al.   ARCHIVES OF NEUROLOGY

Drugs: A tangled web of targets

(2011) Lauren Gravitz   NATURE

Causes versus effects: the increasing complexities of Alzheimer’s disease pathogenesis

(2010) Siddhartha Mondragón-Rodríguez et al.   Expert Review of Neurotherapeutics

Tau phosphorylation: the therapeutic challenge for neurodegenerative disease

(2009) Diane P. Hanger et al.   TRENDS IN MOLECULAR MEDICINE

Thiazin red as a neuropathological tool for the rapid diagnosis of Alzheimer’s disease in tissue imprints

(2008) José Luna-Muñoz et al.   ACTA NEUROPATHOLOGICA

Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer’s disease

(2008) Siddhartha Mondragón-Rodríguez et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY